MB Pharma

🚨 Registration for VoM2026 is now OPEN! 🚨

Science lovers, this one’s for you 🧪🦠

Viruses of Microbes 2026 will bring top experts, cutting-edge research, and lively discussions to Prague — and yes, you can already sign up (even before Christmas 🎄😄).
At MB Pharma, we’re excited to follow and support a conference that connects fundamental research with real-world innovation and collaboration.
A perfect excuse to plan something exciting for 2026 — beyond the holiday season 😉
👉 Check the official registration VoM2026 post for details and updates!

Still looking for the perfect Christmas gift? We have good news, the registration is ON. Check https://www.vom2026.org/registration

💡 Big news from MB PHARMA! 🚀

We’re kicking off a new project focused on advanced lyophilization technology to create a stable, lyophilized form of bacteriophage lysates. This innovation will extend shelf life, simplify storage and logistics, and support large-scale production of next-generation phage therapeutics 🦠.

This project is co-funded by the European Union through the Operational Programme Technology and Application for Competitiveness (OP TAK) and the Ministry of Industry and Trade of the Czech Republic 🇪🇺🤝🇨🇿

🎲✨ EU Horizon phage call = closed!
Our friends and partners have sent in their projects after weeks of hard work, coffee, and late-night writing sessions.

Now comes the lottery of innovation… who will get picked? 🤞🦠🚀

Good luck to everyone who submitted — respect for the effort! 👏

We were there! 🙌

The Targeting Phage Therapy 2025 Congress in Berlin brought together researchers from all over the world — and we’re proud to say our team was part of it.

🧬 We presented our latest work in three presentations and four posters, had great conversations, and came back full of ideas and inspiration.

Big thanks to the organizers Targeting Phage Therapy for a fantastic event! 👏

We're already looking forward to the next one.